Physician profile
Dru Dethlefs
NPI 1518304708
$5,263.28
in general payments reported to CMS, 2019-2025
10 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,724 · 2020: $467 · 2021: $1,091 · 2022: $947 · 2023: $633 · 2024: $299 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997 · Education: $36.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.45 |
| Education | $36.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $3,673.98 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $522.67 | 2019-2024 | Apollo Esg System |
| Abbott Laboratories | $346.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $188.72 | 2019 | |
| Penumbra, INC. | $142.22 | 2022 | |
| Impulse Dynamics (USA) INC. | $137.58 | 2022 | |
| Alexion Pharmaceuticals, INC. | $120.91 | 2019 | |
| Astellas Pharma US INC | $88.11 | 2025 | Cresemba |
| Pfizer INC. | $28.30 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.76 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dru Dethlefs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.